{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:25:22Z","timestamp":1784795122338,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.msard.2021.103040","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:11:04Z","timestamp":1621617064000},"page":"103040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma"],"prefix":"10.1016","volume":"53","author":[{"given":"Alena","family":"Sorensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon S.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1359","authenticated-orcid":false,"given":"Farren B.S.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103040_bib0001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1352458516650512","article-title":"Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course","volume":"23","author":"Conway","year":"2017","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2021.103040_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2019.01.045","article-title":"Prognostic factors of disability in relapsing remitting multiple sclerosis","volume":"30","author":"Briggs","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103040_bib0004","article-title":"Estimating the prevalence of multiple sclerosis using 56.6 million electronic health records from the United States","author":"Briggs","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.103040_bib0005","article-title":"The prevalence of hypertension in multiple sclerosis based on 37 million electronic health records from the United States","author":"Briggs","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0006","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7224\/1537-2073-11.1.6","article-title":"Comorbidity and Health-Related Quality of Life in People with Multiple Sclerosis","volume":"11","author":"Warren","year":"2009","journal-title":"Int J MS Care"},{"key":"10.1016\/j.msard.2021.103040_bib0007","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103040_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fneur.2018.00487","article-title":"Effects of systolic blood pressure on brain integrity in multiple sclerosis","volume":"9","author":"Dossi","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.13769","article-title":"Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study","volume":"26","author":"Jakimovski","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00467-011-1928-4","article-title":"Glucocorticoid-induced hypertension","volume":"27","author":"Goodwin","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.msard.2021.103040_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.msard.2021.103040_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/PROM.S148387","article-title":"Comorbidity in US patients with multiple sclerosis","volume":"9","author":"Edwards","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.msard.2021.103040_bib0013","first-page":"1","article-title":"Total and high-density lipoprotein cholesterol in adults: United States, 2015-2016","author":"Carroll","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.msard.2021.103040_bib0014","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103040_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.msard.2018.12.012","article-title":"Prevalence of asthma in multiple sclerosis: a United States population-based study","volume":"28","author":"Hill","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2021.103040_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007806","article-title":"Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study","volume":"5","author":"Manouchehrinia","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.msard.2021.103040_bib0017","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jval.2012.08.2208","article-title":"The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy","volume":"16","author":"Jia","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.msard.2021.103040_bib0018","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41598-018-38461-y","article-title":"Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults","volume":"9","author":"Yi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2021.103040_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2021.103040_bib0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4168\/aair.2018.10.5.428","article-title":"Autoimmune Responses in Severe Asthma","volume":"10","author":"Mukherjee","year":"2018","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.msard.2021.103040_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2018.05.085","article-title":"Hypertension: focus on autoimmunity and oxidative stress","volume":"125","author":"Small","year":"2018","journal-title":"Free Radic Biol. Med."},{"key":"10.1016\/j.msard.2021.103040_bib0022","unstructured":"Know Your Risk for High Blood Pressure (https:\/\/www.cdc.gov\/bloodpressure\/risk_factors.htm; Updated: February 24, 2020; Accessed: April 5, 2021)."},{"key":"10.1016\/j.msard.2021.103040_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/HJH.0000000000000428","article-title":"Socioeconomic status and hypertension: a meta-analysis","volume":"33","author":"Leng","year":"2015","journal-title":"J. Hypertens"},{"key":"10.1016\/j.msard.2021.103040_bib0024","doi-asserted-by":"crossref","DOI":"10.15713\/ins.johtn.0114","article-title":"The dual burden of hypertension and hyperlipidemia","volume":"4","author":"Tan","year":"2018","journal-title":"Hypertension J."},{"key":"10.1016\/j.msard.2021.103040_bib0025","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1800345","article-title":"Treatment of hypertension in patients with asthma","volume":"381","author":"Christiansen","year":"2019","journal-title":"N Eng. J. Med."},{"key":"10.1016\/j.msard.2021.103040_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101423","article-title":"Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study","volume":"37","author":"Persson","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.msard.2021.103040_bib0027","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp-2015-310361","article-title":"Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios","volume":"87","author":"Manouchehrinia","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2021.103040_bib0028","unstructured":"Knowing Your Risk for High Cholesterol. (https:\/\/www.cdc.gov\/cholesterol\/risk_factors.htm; Updated: January 31, 2020; Accessed: April 5, 2021)."},{"key":"10.1016\/j.msard.2021.103040_bib0029","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns","volume":"129","author":"Frank","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2021.103040_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaci.2015.05.033","article-title":"Blood lipid levels associate with childhood asthma, airway obstruction, bronchial hyperresponsiveness, and aeroallergen sensitization","volume":"137","author":"Vinding","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2021.103040_bib0031","unstructured":"Most Recent National Asthma Data. (https:\/\/www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm; Updated: October 26, 2020; Accessed: April 5, 2021)."},{"key":"10.1016\/j.msard.2021.103040_bib0032","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1183\/09031936.00192408","article-title":"Body mass index as predictor for asthma: a cohort study of 118,723 males and females","volume":"35","author":"Hjellvik","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.msard.2021.103040_bib0033","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.rmed.2019.01.014","article-title":"Epidemiology and risk factors for asthma","volume":"149","author":"Kuruvilla","year":"2019","journal-title":"Respir Med."},{"key":"10.1016\/j.msard.2021.103040_bib0034","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000334107","article-title":"Anaphylactic reaction after injection of glatiramer acetate (Copaxone(R)) in patients with relapsing-remitting multiple sclerosis","volume":"66","author":"Baumgartner","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1189\/jlb.3RU0315-099R","article-title":"Interferon at the crossroads of allergy and viral infections","volume":"98","author":"Gonzales-van Horn","year":"2015","journal-title":"J. Leukoc Biol."},{"key":"10.1016\/j.msard.2021.103040_bib0036","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2010.143","article-title":"Life issues in multiple sclerosis","volume":"6","author":"Simmons","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2021.103040_bib0037","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/acr.23574","article-title":"Lipid testing and statin prescriptions among medicaid recipients with systemic lupus erythematosus or diabetes mellitus and the general medicaid population","volume":"71","author":"Chen","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.msard.2021.103040_bib0038","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/acr.23810","article-title":"Screening of hyperlipidemia among patients with rheumatoid arthritis in the United States","volume":"71","author":"Navarro-Millan","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.msard.2021.103040_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101987","article-title":"Management of diabetes and hypertension in people with multiple sclerosis","volume":"40","author":"Marrie","year":"2020","journal-title":"Mult. Scler. Relat Disord."},{"key":"10.1016\/j.msard.2021.103040_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ypmed.2014.04.026","article-title":"Explaining racial and ethnic disparities in cholesterol screening","volume":"65","author":"Kenik","year":"2014","journal-title":"Prev Med."},{"key":"10.1016\/j.msard.2021.103040_bib0041","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11606-017-3999-9","article-title":"Disparities in hypertension associated with limited english proficiency","volume":"32","author":"Kim","year":"2017","journal-title":"J. Gen. Intern Med."},{"key":"10.1016\/j.msard.2021.103040_bib0042","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s11606-018-4471-1","article-title":"Racial and ethnic disparities in diagnosis of chronic medical conditions in the USA","volume":"33","author":"Kim","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.msard.2021.103040_bib0043","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jaci.2018.11.022","article-title":"Racial disparities in asthma-related health care use in the national heart, lung, and blood institute's severe asthma research program","volume":"143","author":"Fitzpatrick","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2021.103040_bib0044","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.mcna.2009.02.007","article-title":"Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults","volume":"93","author":"Krousel-Wood","year":"2009","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.msard.2021.103040_bib0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/jgs.12171","article-title":"Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults","volume":"61","author":"Holt","year":"2013","journal-title":"J. Am. Geriatr Soc."},{"key":"10.1016\/j.msard.2021.103040_bib0046","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/imj.13687","article-title":"Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study","volume":"48","author":"Hennein","year":"2018","journal-title":"Intern Med. J."},{"key":"10.1016\/j.msard.2021.103040_bib0047","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2018.03.024","article-title":"Barriers to medication adherence in asthma: the importance of culture and context","volume":"121","author":"McQuaid","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.msard.2021.103040_bib0048","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.pec.2019.02.022","article-title":"Health beliefs and medication adherence in patients with hypertension: A systematic review of quantitative studies","volume":"102","author":"Al-Noumani","year":"2019","journal-title":"Patient Educ. Couns."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821003072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:59:29Z","timestamp":1761901169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821003072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":48,"alternative-id":["S2211034821003072"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103040","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103040"}}